Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin

Clinical trial NCT05036421 · COMPLETED

Trial details

NCT number: NCT05036421
Sponsor: Ain Shams University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pharmacogenomic Pharmacokinetics

Start date: 2022-02-15
Primary completion: 2022-05-20
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.